Literature DB >> 8426871

Dose conversion and wall correction factors for Fricke dosimetry in high-energy photon beams: analytical model and Monte Carlo calculations.

C M Ma1, A E Nahum.   

Abstract

This paper presents the dose conversion and wall correction factors for Fricke dosimetry in high-energy photon beams calculated using both an analytical general cavity model and Monte Carlo techniques. The conversion factor is calculated as the ratio of the absorbed dose in water to that in the Fricke dosimeter solution with a water-walled vessel. The wall correction factor accounts for the change in the absorbed dose to the dosimeter solution caused by the inhomogeneous dosimeter wall material. A usercode based on the EGS4 Monte Carlo system, with the application of a correlated sampling variance reduction technique, has been employed in the calculations of these factors and the parameters used in the cavity model. Good agreement has been achieved between the predictions of the model and that obtained by direct Monte Carlo simulation and also with other workers' experiments. It is shown that Fricke dosimeters in common use cannot be considered to be 'large' detectors and therefore 'general cavity theory' should be applied in converting the dose to water. It is confirmed that plastic dosimeter vessels have a negligible wall effect. The wall correction factor for a 1 mm thick Pyrex-walled vessel varies with incident photon energy from 1.001 +/- 0.001 for a 60Co beam to 0.983 +/- 0.001 for a 24 MV (TPR(10)20 = 0.80) photon beam. This implies that previous Fricke measurements with glass-walled vessels should be re-evaluated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426871     DOI: 10.1088/0031-9155/38/1/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

1.  A feasibility study of Fricke dosimetry as an absorbed dose to water standard for 192Ir HDR sources.

Authors:  Carlos Eduardo deAlmeida; Ricardo Ochoa; Marilene Coelho de Lima; Mariano Gazineu David; Evandro Jesus Pires; José Guilherme Peixoto; Camila Salata; Mario Antônio Bernal
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.